Hepatitis E Virus Infection in Pediatric Oncology.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
received:
03
09
2021
accepted:
02
06
2022
pubmed:
5
1
2023
medline:
7
1
2023
entrez:
4
1
2023
Statut:
ppublish
Résumé
In the 2016 ESPGHAN recommendations on how to deal with hepatitis E virus infection in immunocompromised children, patients treated with chemotherapy were not specifically mentioned. Two teenagers treated with chemotherapy for acute leukemia and medulloblastoma, respectively, were diagnosed with hepatic cytolysis. After numerous investigations hepatitis E was found, limiting the good progress of the chemotherapy treatment. In the case of liver cytolysis in immunocompromised children treated with chemotherapy, hepatitis E virus infection has to be promptly diagnosed.
Sections du résumé
BACKGROUND
In the 2016 ESPGHAN recommendations on how to deal with hepatitis E virus infection in immunocompromised children, patients treated with chemotherapy were not specifically mentioned.
OBSERVATIONS
Two teenagers treated with chemotherapy for acute leukemia and medulloblastoma, respectively, were diagnosed with hepatic cytolysis. After numerous investigations hepatitis E was found, limiting the good progress of the chemotherapy treatment.
CONCLUSION
In the case of liver cytolysis in immunocompromised children treated with chemotherapy, hepatitis E virus infection has to be promptly diagnosed.
Identifiants
pubmed: 36598968
doi: 10.1097/MPH.0000000000002539
pii: 00043426-202301000-00043
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e150-e153Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Colson P, Coze C. Transfusion-associated hepatitis E, France. Emerg Infect Dis. 2007;13:647.
Motte A, Roquelaure B, Galambrun C, et al. Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol. 2012;53:162–166.
Blasco Perrin H, Abravanel F, Péron JM. Hepatitis E Virus in France, recent epidemiological and clinical data. Hépato Gastro. 2015;22:795–802.
Kamar N, Sleves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–817.
Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:1111–1120.
Fischler B, Baumann U, Dezsofi A, et al. Hepatitis E in children: a position paper by the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2016;63:288–294.
Dalton HR, Kamar N, Baylis S, et al. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256–1271.
Verghese VP, Robinson JL. A systematic review of hepatitis E virus infection in children. Clin Infect Dis. 2014; 59: 689–697.
Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology. 2012;142:1388–1397.e1.